A third of leukaemia patients do not generate antibody response to two doses of COVID-19 vaccination

Dr Helen Parry describes the findings of a new University of Birmingham-led study which has shown that a third of patients with the most common type of leukaemia fail to generate any measurable antibody response following two doses of COVID-19 vaccination. Furthermore, the research showed that in the two thirds of patients who do develop antibodies, levels are much lower than compared to healthy people and also have a profoundly reduced ability to ‘neutralise’ the globally dominant Delta variant.

Find out more at:

Leave a Reply

Your email address will not be published.